Patent Assignment
Reel/Frame 064014/0797
Assignment of Assignor's Interest
Recorded: 2023-06-21
Pages: 11
Assignee
DRACEN PHARMACEUTICALS, INC.
C/O STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C., 1100 NEW YORK AVENUE, NW, WASHINGTON, DISTRICT OF COLUMBIA, 20005
Covered Property
(1)
NRF2 Protein Degraders
Application:
63/355,834 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Jul 12, 2023
From: DRACEN PHARMACEUTICALS, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AS COLLATERAL AGENT
Reel/Frame 064232/0765 →
Release of Security Interest
May 14, 2024
From: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AS COLLATERAL AGENT
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 067405/0368 →
Assignment of Assignor's Interest
Jul 10, 2024
From: DRACEN PHARMACEUTICALS, INC.
To: GANYMEDE ONCOLOGY, INC.
Reel/Frame 067951/0276 →